Rare Ovarian Cancer GOG 268

March 13, 2013

Location: The Hospital of Central Connecticut

A Phase II Evaluation Of Temsirolimus Combination With Carboplatin And Paclitaxel Followed By Temsirolimus Consolidation As First-Line Therapy In The Treatment Of Stage III-IV Clear Cell Carcinoma Of The Ovary.